AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $52,000 | +100.0% | 3,408 | -1.4% | 0.00% | +100.0% |
| Q2 2022 | $26,000 | -54.4% | 3,458 | -45.2% | 0.00% | -33.3% |
| Q1 2022 | $57,000 | +29.5% | 6,308 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $44,000 | -50.0% | 6,308 | -18.2% | 0.00% | -60.0% |
| Q3 2021 | $88,000 | -28.5% | 7,708 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $123,000 | -10.9% | 7,708 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $138,000 | +32.7% | 7,708 | 0.0% | 0.01% | +33.3% |
| Q4 2020 | $104,000 | -24.6% | 7,708 | -24.5% | 0.01% | -57.1% |
| Q1 2020 | $138,000 | -69.7% | 10,208 | -45.9% | 0.01% | -61.1% |
| Q4 2019 | $456,000 | +13.4% | 18,861 | -9.9% | 0.04% | +2.9% |
| Q3 2019 | $402,000 | -35.5% | 20,926 | -0.7% | 0.04% | -37.5% |
| Q2 2019 | $623,000 | -38.4% | 21,076 | -1.1% | 0.06% | -40.4% |
| Q1 2019 | $1,012,000 | -3.3% | 21,301 | -26.5% | 0.09% | -16.8% |
| Q4 2018 | $1,046,000 | -55.7% | 28,973 | -24.4% | 0.11% | -45.4% |
| Q3 2018 | $2,360,000 | – | 38,340 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|